effect of salmali and ulatkambal on Kashtartwa also known as dysmenorrhea.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N946- Dysmenorrhea, unspecified
- Registration Number
- CTRI/2023/03/050462
- Lead Sponsor
- Government Ayurvedic College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients will pay for trial.
2.The sign and symptoms based on both Ayurvedic as well as Modern view.
3.The age group of patients will be between 15 to 45 years.
Exclusion Criteria
ï??Pregnant women
ï??Patients having diabetes,ckd
ï??Patients having secondary hypertension.
ï??Patients suffering from chronic disease like AIDS, CANCER, T.B., CARDIAC COMPLICATIONS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical improvement in kashtartwaTimepoint: 8 week
- Secondary Outcome Measures
Name Time Method Clinical improvement in kashtartwaTimepoint: 15 Days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-dysmenorrheic effects of Salmalia malabaricum and Abroma augusta?
How do Salmalia malabaricum and Abroma augusta compare to standard dysmenorrhea treatments in clinical efficacy?
Are there specific biomarkers associated with response to Salmalia malabaricum or Abroma augusta in primary dysmenorrhea?
What adverse events are reported with Salmalia malabaricum and Abroma augusta for dysmenorrhea management?
What combination therapies or competitor drugs show promise for N946 dysmenorrhea alongside Ayurvedic interventions?